Plain-English translation of ·
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help treat Graves' disease, a condition where your immune system attacks your thyroid gland and makes it produce too much hormone. The study will compare this medication to a placebo (a dummy treatment with no active drug) to understand whether the medication works and how safe it is.
Graves' disease can be hard to manage with current treatments, and some patients need better options. Researchers believe this medication might help by targeting the immune system in a new way to reduce thyroid hormone levels.
You likely qualify if…
You likely don't qualify if…
You would receive multiple intravenous infusions of either the new medication or a placebo at a clinic or hospital. The study involves regular blood tests to check your thyroid hormone levels and antibody counts, plus visits to monitor how you're responding and check for any side effects. Your current anti-thyroid medications would stay at the same dose throughout the study so researchers can see the true effect of the new treatment.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States